Forte Research

Madison, United States Founded: 2000 • Age: 26 yrs Acquired By Advarra
Specialized software for clinical research compliance and efficiency is developed.

About Forte Research

Forte Research is a Healthcare company based in Madison (United States) founded in 2000, and was acquired by Advarra in September 2019. Specialized software for clinical research compliance and efficiency is developed. The company has 181 employees. Its Indian entity Advarra India Private Limited reported revenue of β‚Ή62.58 Cr. Forte Research offers products and services including OnCore, Clinical Conductor, and eReg. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Medidata, Verily and TriNetX; 3 of its 3 listed competitors have raised funding.

Company details

Forte Research Systems,has been developing specialized software for clinical research since 2000. The product family includes OnCore Enterprise Research, Allegro CTMS, and Overture EDC. Forte provides complimentary blog articles, eBooks, webinars and more to support continuous learning on industry topics. With a strong belief in community and standards-based development, Forte also facilitates the Onsemble community, the Allegro Community, and Research Resonance Network, a technology-enabled community of sites pursuing data-driven excellence in clinical research operations.

Key Metrics
  • Indian entity revenue
    ₹62.58 Cr

    FY 2025 · +55% YoY

  • Indian entity net profit
    ₹5.86 Cr

    FY 2025 · 9% margin

  • Indian entity EBITDA
    ₹11.53 Cr

    FY 2025 · 18% margin

  • Investors
    Advarra

    & 1 more

  • Employee Count
    181
  • Acquired by
    Advarra

    (Sep 2019)

Products & Services of Forte Research

Forte Research offers a comprehensive portfolio of products and services, including OnCore, Clinical Conductor, and eReg.

OnCore
Clinical Trial Management

System for operations and financial management in high-volume research sites.

Clinical Conductor
Research Operations

Suite for optimizing clinical research workflows and site growth.

eReg
eRegulatory Management

Platform for compliant and paperless regulatory processes.

Funding Insights of Forte Research

  • Total Rounds 2
  • First Round $550,000

    (Sep 2014)

  • Investors Count 1

All 2 funding rounds of Forte Research with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2015Private Equity Round–Primus Capital
–
Sep 2014$550,000Debt – Conventional––
–
Valuation history

2 investors in total: 2 institutional.

Investors in Forte Research

Forte Research has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Advarra and Primus Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity investments are directed toward the US and Canada.
primuscapital.comCleveland, United States
Global research compliance services including IRB and consulting are provided.
2017advarra.comColumbia, United States
Premium access

Investor details for Forte Research

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Advarra India Private Limited (Forte Research)

Advarra India Private Limited is the primary company behind Forte Research. The board of Advarra India Private Limited currently have 5 directors; the longest-serving is Orla Elizabeth Mester, appointed in 2017. 9 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Orla Elizabeth Mester
DIN 08016955
Director13 Dec 20178 yrs 11 moAdvarra India Private Limited
Vinaykumar Venkatachalapathi Nama
DIN 08087724
Whole-time director11 May 20188 yrs 6 moAdvarra India Private Limited
Scott Edward Uebele
DIN 10597595
Director08 May 20242 yrs 6 moAdvarra India Private Limited
Swetha Raju
DIN 10692573
Whole-time director13 Sep 20242 yrs 2 moAdvarra India Private Limited
Marco Vincent Capasso
DIN 08621820
Director19 May 20251 yr 5 moAdvarra India Private Limited

Financials of Forte Research

Figures of Advarra India Private Limited, the primary company behind Forte Research, for FY 2025. Revenue was ₹62.58 Cr (+55% year on year). Net profit was ₹5.86 Cr (9% margin). EBITDA was ₹11.53 Cr (18% margin). Revenue has grown at a compounded annual rate of +50% over three years and +37% over five years.

  • ₹62.58 CrRevenue · FY 2025 · +55% YoY
  • ₹5.86 CrNet profit · 9% margin
  • ₹11.53 CrEBITDA · 18% margin
  • ₹1 LakhPaid-up capital
  • 249Employees (provident fund records)
  • +50%Revenue CAGR, 3 years
  • +37%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Advarra India Private Limited are on its company page.

Premium access

Detailed financial statements for Forte Research

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Forte Research

4 dated milestones of Forte Research across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Forte Research is founded.
  2. Funding First funding round of $550K.
  3. Funding Latest funding round, Private Equity Round,.
  4. Exit Acquired by Advarra.

Competitors of Forte Research

Forte Research has 3 listed competitors in our database, 3 of them funded. They include Medidata, Verily and TriNetX.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
medidata.com1999New York, United States$41.5M1,677
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
verily.com2015Dallas, United States$2.5B
AI-based solutions for health management are provided.
trinetx.com2013Cambridge, United States$53M95
Clinical trial management software is provided for researchers and professionals.
Premium access

Detailed competitors of Forte Research

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Forte Research

Websites that share an audience with Forte Research (forteresearch.com).

Similar websites

Websites whose visitors overlap most with Forte Research. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
pacra.org
pacra.org
100%
#12,073,368–
clintec.com
100%
View details
clinicalrm.com
99%
View details
chcuk.co.uk
chcuk.co.uk
98%
–
xstrahl.com
62%
4.8K#4,200,261View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 9 similar websites and full traffic analytics for Forte Research

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 9 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Forte Research (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Forte Research

Premium access

Complete news archive for Forte Research

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Forte Research

Forte Research was founded in 2000 and raised its 1st funding round 14 years after it was founded.

Forte Research is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.

Forte Research has 181 employees.

The primary company behind Forte Research, Advarra India Private Limited, reported revenue of β‚Ή62.58 Cr for FY 2025, up 55% year on year.

Forte Research Systems,has been developing specialized software for clinical research since 2000. The product family includes OnCore Enterprise Research, Allegro CTMS, and Overture EDC. Forte provides complimentary blog articles, eBooks, webinars and more to support continuous learning on industry topics. With a strong belief in community and standards-based development, Forte also facilitates the Onsemble community, the Allegro Community, and Research Resonance Network, a technology-enabled community of sites pursuing data-driven excellence in clinical research operations.

Forte Research's top competitors include Medidata, Verily and TriNetX.

Forte Research offers OnCore, Clinical Conductor, and eReg.

Forte Research has 2 investors. Key investors include Advarra, and Primus Capital.

Forte Research operates through Advarra India Private Limited.

Yes. Forte Research was acquired by Advarra in September 2019.

The legal entities of Forte Research currently have 5 directors, including Marco Vincent Capasso, Scott Edward Uebele, Orla Elizabeth Mester and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available